Dasatinib dose management for the treatment of chronic myeloid leukemia

بواسطة Talpaz, Moshe, Saglio, Giuseppe, Atallah, Ehab, Rousselot, Philippe
الحاوية / القاعدة Cancer (2018)

Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remission

بواسطة Rousselot, Philippe, Loiseau, Clémence, Delord, Marc, Cayuela, Jean Michel, Spentchian, Marc
الحاوية / القاعدة Blood Adv (2020)

Second attempt to discontinue imatinib in CP-CML patients with a second sustained complete molecular response

بواسطة Legros, Laurence, Rousselot, Philippe, Giraudier, Stéphane, Tulliez, Michel, Huguet, Françoise, Nicolini, Franck-Emmanuel, Mahon, Francois-Xavier
منشور في 2012

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review

بواسطة Cortes, Jorge E., Apperley, Jane F., DeAngelo, Daniel J., Deininger, Michael W., Kota, Vamsi K., Rousselot, Philippe, Gambacorti-Passerini, Carlo
الحاوية / القاعدة J Hematol Oncol (2018)

Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders

بواسطة Aubry, Alban, Porcher, Raphael, Bottero, Julie, Touratier, Sophie, Leblanc, Thierry, Brethon, Benoît, Rousselot, Philippe, Raffoux, Emmanuel, Menotti, Jean, Derouin, Francis, Ribaud, Patricia, Sulahian, Annie
منشور في 2006

Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AML

بواسطة Kantarjian, Hagop M, Sekeres, Mikkael A, Ribrag, Vincent, Rousselot, Philippe, Garcia-Manero, Guillermo, Jabbour, Elias J, Owen, Kate, Stockman, Paul K, Oliver, Stuart D
منشور في 2013

Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034

بواسطة Shah, Neil P., Rousselot, Philippe, Schiffer, Charles, Rea, Delphine, Cortes, Jorge E., Milone, Jorge, Mohamed, Hesham, Healey, Diane, Kantarjian, Hagop, Hochhaus, Andreas, Saglio, Giuseppe
الحاوية / القاعدة Am J Hematol (2016)

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia

بواسطة Bruzzoni-Giovanelli, Heriberto, González, Juan R., Sigaux, François, Villoutreix, Bruno O., Cayuela, Jean Michel, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Poyet, Jean-Luc, Rousselot, Philippe
الحاوية / القاعدة Oncotarget (2015)

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

بواسطة Hughes, Timothy P., Laneuville, Pierre, Rousselot, Philippe, Snyder, David S., Rea, Delphine, Shah, Neil P., Paar, David, Abruzzese, Elisabetta, Hochhaus, Andreas, Lipton, Jeffrey H., Cortes, Jorge E.
الحاوية / القاعدة Haematologica (2019)

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin

بواسطة Lambert, Juliette, Lambert, Jérôme, Nibourel, Olivier, Pautas, Cécile, Hayette, Sandrine, Cayuela, Jean-Michel, Terré, Christine, Rousselot, Philippe, Dombret, Hervé, Chevret, Sylvie, Preudhomme, Claude, Castaigne, Sylvie, Renneville, Aline
منشور في 2014

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

بواسطة Bibault, Jean-Emmanuel, Figeac, Martin, Hélevaut, Nathalie, Rodriguez, Céline, Quief, Sabine, Sebda, Shéhérazade, Renneville, Aline, Nibourel, Olivier, Rousselot, Philippe, Gruson, Bérengère, Dombret, Hervé, Castaigne, Sylvie, Preudhomme, Claude
الحاوية / القاعدة Oncotarget (2015)

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients

بواسطة Delord, Marc, Rousselot, Philippe, Cayuela, Jean Michel, Sigaux, François, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Loiseau, Pascale, Raffoux, Emmanuel, Geromin, Daniela, Génin, Emmanuelle, Calvo, Fabien, Bruzzoni-Giovanelli, Heriberto
منشور في 2013

Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study

بواسطة Shah, Neil P., Guilhot, François, Cortes, Jorge E., Schiffer, Charles A., le Coutre, Philipp, Brümmendorf, Tim H., Kantarjian, Hagop M., Hochhaus, Andreas, Rousselot, Philippe, Mohamed, Hesham, Healey, Diane, Cunningham, Michael, Saglio, Giuseppe
الحاوية / القاعدة Blood (2014)

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase ch...

بواسطة Shah, Neil P., Kim, Dong-Wook, Kantarjian, Hagop, Rousselot, Philippe, Llacer, Pedro Enrique Dorlhiac, Enrico, Alicia, Vela-Ojeda, Jorge, Silver, Richard T., Khoury, Hanna Jean, Müller, Martin C., Lambert, Alexandre, Matloub, Yousif, Hochhaus, Andreas
منشور في 2010

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

بواسطة Chomel, Jean Claude, Bonnet, Marie Laure, Sorel, Nathalie, Sloma, Ivan, Bennaceur-Griscelli, Annelise, Rea, Delphine, Legros, Laurence, Marfaing-Koka, Anne, Bourhis, Jean-Henri, Ame, Shanti, Guerci-Bresler, Agnès, Rousselot, Philippe, Turhan, Ali G.
الحاوية / القاعدة Oncotarget (2016)

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34(+) CD15(−) cells in early chronic‐phase chronic myeloid leukemia

بواسطة Maupetit‐Mehouas, Stéphanie, Court, Franck, Bourgne, Céline, Guerci‐Bresler, Agnès, Cony‐Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Rousselot, Philippe, Guyotat, Denis, Janel, Alexandre, Hermet, Eric, Saugues, Sandrine, Berger, Juliette, Arnaud, Philippe, Berger, Marc G.
الحاوية / القاعدة Mol Oncol (2018)

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

بواسطة Löwenberg, Bob, Muus, Petra, Ossenkoppele, Gert, Rousselot, Philippe, Cahn, Jean-Yves, Ifrah, Norbert, Martinelli, Giovanni, Amadori, Sergio, Berman, Ellin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, Rigaudeau, Sophie, Stockman, Paul, Goudie, Alison, Faderl, Stefan, Jabbour, Elias, Kantarjian, Hagop
منشور في 2011

PPARγ agonists promote the resolution of myelofibrosis in preclinical models

بواسطة Lambert, Juliette, Saliba, Joseph, Calderon, Carolina, Sii-Felice, Karine, Salma, Mohammad, Edmond, Valérie, Alvarez, Jean-Claude, Delord, Marc, Marty, Caroline, Plo, Isabelle, Kiladjian, Jean-Jacques, Soler, Eric, Vainchenker, William, Villeval, Jean-Luc, Rousselot, Philippe, Prost, Stéphane
الحاوية / القاعدة J Clin Invest (2021)

Rapid screening of COVID‐19 patients using white blood cell scattergrams, a study on 381 patients

بواسطة Osman, Jennifer, Lambert, Jérome, Templé, Marie, Devaux, Floriane, Favre, Rémy, Flaujac, Claire, Bridoux, Delphine, Marque‐Juillet, Stéphanie, Bruneel, Fabrice, Mignon, François, Diaz‐Flores, Ernesto, Hentgen, Véronique, Greder‐Belan, Alix, Azarian, Reza, Koukabi, Mehrsa, Rousselot, Philippe, Raggueneau, Victoria, Manéglier, Benjamin
الحاوية / القاعدة Br J Haematol (2020)

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

بواسطة Guignabert, Christophe, Phan, Carole, Seferian, Andrei, Huertas, Alice, Tu, Ly, Thuillet, Raphaël, Sattler, Caroline, Le Hiress, Morane, Tamura, Yuichi, Jutant, Etienne-Marie, Chaumais, Marie-Camille, Bouchet, Stéphane, Manéglier, Benjamin, Molimard, Mathieu, Rousselot, Philippe, Sitbon, Olivier, Simonneau, Gérald, Montani, David, Humbert, Marc
الحاوية / القاعدة J Clin Invest (2016)